By Amy Graff, SFGATE
SFGATE
April 27, 2021
UCSF reported Sunday it’s treating a patient who was admitted to the hospital with a rare blood clot 13 days after receiving the Johnson & Johnson vaccine.
This is the first male patient to develop the condition known as vaccine-induced thrombotic thrombocytopenia (VITT) in the country, UCSF said in a statement.